User profiles for Gerd Geisslinger
Prof. Dr. Dr. Gerd GeisslingerProfessor für Klinische Pharmakologie - Goethe-Universität Verified email at em.uni-frankfurt.de Cited by 37640 |
Cyclooxygenase‐independent actions of cyclooxygenase inhibitors
I Tegeder, J Pfeilschifter, G Geisslinger - The FASEB Journal, 2001 - Wiley Online Library
Several studies have demonstrated unequivocally that certain nonsteroidal anti‐inflammatory
drugs (NSAIDs) such as sodium salicylate, sulindac, ibuprofen, and flurbiprofen cause anti…
drugs (NSAIDs) such as sodium salicylate, sulindac, ibuprofen, and flurbiprofen cause anti…
Cyclooxygenase-2 (COX-2)–independent anticarcinogenic effects of selective COX-2 inhibitors
…, TJ Maier, S Schiffmann, G Geisslinger - Journal of the National …, 2006 - academic.oup.com
Nonsteroidal antiinflammatory drugs (NSAIDs) appear to reduce the risk of developing
cancer. One mechanism through which NSAIDs act to reduce carcinogenesis is to inhibit the …
cancer. One mechanism through which NSAIDs act to reduce carcinogenesis is to inhibit the …
Chain length-specific properties of ceramides
S Grösch, S Schiffmann, G Geisslinger - Progress in lipid research, 2012 - Elsevier
Ceramides are a class of sphingolipids that are abundant in cell membranes. They are
important structural components of the membrane but can also act as second messengers in …
important structural components of the membrane but can also act as second messengers in …
COX‐2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX‐2 inhibitor celecoxib
…, E Niederberger, L Bräutigam, G Geisslinger - The FASEB …, 2001 - Wiley Online Library
The regular use of various nonsteroidal anti‐inflammatory drugs (NSAIDs) was shown to
decrease the incidence of colorectal cancer. This effect is thought to be caused predominantly …
decrease the incidence of colorectal cancer. This effect is thought to be caused predominantly …
GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence
We report that GTP cyclohydrolase (GCH1), the rate-limiting enzyme for tetrahydrobiopterin (BH4)
synthesis, is a key modulator of peripheral neuropathic and inflammatory pain. BH4 is …
synthesis, is a key modulator of peripheral neuropathic and inflammatory pain. BH4 is …
[PDF][PDF] The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2
Neurological complications are common in COVID-19. Although SARS-CoV-2 has been
detected in patients' brain tissues, its entry routes and resulting consequences are not well …
detected in patients' brain tissues, its entry routes and resulting consequences are not well …
COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites
M Burian, G Geisslinger - Pharmacology & therapeutics, 2005 - Elsevier
Despite the diverse chemical structure of aspirin-like drugs, the antinociceptive effect of
NSAIDs is mainly due to their common property of inhibiting cyclooxygenases involved in the …
NSAIDs is mainly due to their common property of inhibiting cyclooxygenases involved in the …
Ziconotide for treatment of severe chronic pain
A Schmidtko, J Lötsch, R Freynhagen, G Geisslinger - The Lancet, 2010 - thelancet.com
Pharmacological management of severe chronic pain is difficult to achieve with currently
available analgesic drugs, and remains a large unmet therapeutic need. The synthetic peptide …
available analgesic drugs, and remains a large unmet therapeutic need. The synthetic peptide …
Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer
…, S Schiffmann, S Grösch, G Geisslinger… - Breast cancer research …, 2008 - Springer
Beside their structural role for the cell membrane the family of sphingolipids act as effector
molecules in signal transduction with links to various aspects of cancer initiation, progression …
molecules in signal transduction with links to various aspects of cancer initiation, progression …
Pharmacokinetics of opioids in liver disease
I Tegeder, J Lötsch, G Geisslinger - Clinical pharmacokinetics, 1999 - Springer
The liver is the major site of biotransformation for most opioids. Thus, the disposition of these
drugs may be affected in patients with liver insufficiency. The major metabolic pathway for …
drugs may be affected in patients with liver insufficiency. The major metabolic pathway for …